Literature DB >> 15228413

Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review.

S Tangjitgamol1, C F Levenback, U Beller, J J Kavanagh.   

Abstract

Many reports of ovarian, cervical, and uterine cancers metastatic to lung, liver, and brain have been published. A fewer number of them focused on the surgical treatment for these patients. We reviewed the published literature, regarding surgical management of metastatic disease in patients with gynecological cancer. Some prognostic factors in the patients with metastatic lesions from these three different cancers were found in common. Favorable prognostic factors for a prolonged survival were good performance status of the patients, long disease-free interval, absence of other systemic disease, and the resectability, preferably with a clear margin. These factors should be considered as the criteria for surgery. In well-selected patients, survival could be extended from the surgical procedure with minimal complications. Other types of treatment such as radiation therapy or chemotherapy could also be given in conjunction with surgery, depending on tumor type and disease status of the primary cancer, other systemic diseases, and residual metastatic lesions after surgery.

Entities:  

Mesh:

Year:  2004        PMID: 15228413     DOI: 10.1111/j.1048-891x.2004.14326.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  22 in total

1.  Metastasis of squamous cell cervical carcinoma to the orbit of the eye.

Authors:  Pratibha Sareen; Roberta E Blandon; Nicholas R Binder; Darryl L Wallace
Journal:  Gynecol Oncol Case Rep       Date:  2012-04-09

Review 2.  Locoregional Therapies for the Treatment of Hepatic Metastases from Breast and Gynecologic Cancers.

Authors:  Samdeep K Mouli; Ramona Gupta; Neil Sheth; Andrew C Gordon; Robert J Lewandowski
Journal:  Semin Intervent Radiol       Date:  2018-04-05       Impact factor: 1.513

3.  Hematogenous metastases in patients with Stage I or II endometrial carcinoma.

Authors:  Paweł Blecharz; Krzysztof Urbański; Anna Mucha-Małecka; Krzysztof Małecki; Marian Reinfuss; Jerzy Jakubowicz; Piotr Skotnicki
Journal:  Strahlenther Onkol       Date:  2011-11-17       Impact factor: 3.621

4.  The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma.

Authors:  Sarah I Kamel; Mechteld C de Jong; Richard D Schulick; Teresa P Diaz-Montes; Christopher L Wolfgang; Kenzo Hirose; Barish H Edil; Michael A Choti; Robert A Anders; Timothy M Pawlik
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

5.  Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis.

Authors:  Monique A Spillman; Nicole G Manning; Wendy W Dye; Carol A Sartorius; Miriam D Post; Joshua Chuck Harrell; Britta M Jacobsen; Kathryn B Horwitz
Journal:  Cancer Res       Date:  2010-10-19       Impact factor: 12.701

Review 6.  Hepatic resection for metastatic endometrioid carcinoma.

Authors:  Brett Knowles; Christopher O C Bellamy; Anca Oniscu; Stephen J Wigmore
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

7.  Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain.

Authors:  Laura M Divine; Nora T Kizer; Andrea R Hagemann; Meredith E Pittman; Ling Chen; Matthew A Powell; David G Mutch; Janet S Rader; Premal H Thaker
Journal:  Gynecol Oncol       Date:  2016-05-08       Impact factor: 5.482

Review 8.  Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer.

Authors:  Maria Luisa Gasparri; Giovanni Grandi; Daniele Bolla; Beat Gloor; Sara Imboden; Pierluigi Benedetti Panici; Michael D Mueller; Andrea Papadia
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-11       Impact factor: 4.553

9.  Quinary debulking for epithelial ovarian cancer.

Authors:  James M Edwards; William Jeffrey Lowery; Angeles Alvarez Secord
Journal:  J Surg Case Rep       Date:  2012-07-01

10.  Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway.

Authors:  Ruey-Hwang Chou; Shu-Ching Hsieh; Yung-Luen Yu; Min-Hsien Huang; Yi-Chang Huang; Yi-Hsien Hsieh
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.